250 related articles for article (PubMed ID: 11560954)
21. Activated Raf-1 causes growth arrest in human small cell lung cancer cells.
Ravi RK; Weber E; McMahon M; Williams JR; Baylin S; Mal A; Harter ML; Dillehay LE; Claudio PP; Giordano A; Nelkin BD; Mabry M
J Clin Invest; 1998 Jan; 101(1):153-9. PubMed ID: 9421477
[TBL] [Abstract][Full Text] [Related]
22. Notch-1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways.
Jang MS; Miao H; Carlesso N; Shelly L; Zlobin A; Darack N; Qin JZ; Nickoloff BJ; Miele L
J Cell Physiol; 2004 Jun; 199(3):418-33. PubMed ID: 15095289
[TBL] [Abstract][Full Text] [Related]
23. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
24. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
[TBL] [Abstract][Full Text] [Related]
25. MEK blockade converts AML differentiating response to retinoids into extensive apoptosis.
Milella M; Konopleva M; Precupanu CM; Tabe Y; Ricciardi MR; Gregorj C; Collins SJ; Carter BZ; D'Angelo C; Petrucci MT; FoĆ R; Cognetti F; Tafuri A; Andreeff M
Blood; 2007 Mar; 109(5):2121-9. PubMed ID: 17077328
[TBL] [Abstract][Full Text] [Related]
26. Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells.
Chen D; Heath V; O'Garra A; Johnston J; McMahon M
J Immunol; 1999 Dec; 163(11):5796-805. PubMed ID: 10570262
[TBL] [Abstract][Full Text] [Related]
27. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
28. The mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma cell lines.
Mattingly RR; Kraniak JM; Dilworth JT; Mathieu P; Bealmear B; Nowak JE; Benjamins JA; Tainsky MA; Reiners JJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):456-65. PubMed ID: 16239399
[TBL] [Abstract][Full Text] [Related]
29. Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53.
Lee SW; Fang L; Igarashi M; Ouchi T; Lu KP; Aaronson SA
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8302-5. PubMed ID: 10890907
[TBL] [Abstract][Full Text] [Related]
30. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
[TBL] [Abstract][Full Text] [Related]
31. Activation of the MEK/MAPK pathway is involved in bryostatin1-induced monocytic differenciation and up-regulation of X-linked inhibitor of apoptosis protein.
Lin H; Chen C; Li X; Chen BD
Exp Cell Res; 2002 Jan; 272(2):192-8. PubMed ID: 11777344
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional and ERK1/2-dependent synergistic upregulation of p21(cip1/waf1) associated with steel factor synergy in MO7e.
Lee Y; Mantel C; Anzai N; Braun SE; Broxmeyer HE
Biochem Biophys Res Commun; 2001 Jan; 280(3):675-83. PubMed ID: 11162574
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1).
Barata JT; Cardoso AA; Nadler LM; Boussiotis VA
Blood; 2001 Sep; 98(5):1524-31. PubMed ID: 11520803
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells.
Stadheim TA; Xiao H; Eastman A
Cancer Res; 2001 Feb; 61(4):1533-40. PubMed ID: 11245462
[TBL] [Abstract][Full Text] [Related]
35. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
36. Monensin-mediated growth inhibition in acute myelogenous leukemia cells via cell cycle arrest and apoptosis.
Park WH; Lee MS; Park K; Kim ES; Kim BK; Lee YY
Int J Cancer; 2002 Sep; 101(3):235-42. PubMed ID: 12209973
[TBL] [Abstract][Full Text] [Related]
37. Insulin is a potent survival factor in mesangial cells: role of the PI3-kinase/Akt pathway.
Hiromura K; Monkawa T; Petermann AT; Durvasula RV; Shankland SJ
Kidney Int; 2002 Apr; 61(4):1312-21. PubMed ID: 11918738
[TBL] [Abstract][Full Text] [Related]
38. PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase.
Ghosh SS; Gehr TW; Ghosh S; Fakhry I; Sica DA; Lyall V; Schoolwerth AC
Kidney Int; 2003 Jul; 64(1):52-62. PubMed ID: 12787395
[TBL] [Abstract][Full Text] [Related]
39. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
40. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
Dai Y; Rahmani M; Grant S
Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]